Thus, a reduced AHR content is frequently found in people with chronic exposure to exogenous AHR ligands and is accompanied by a series of pathologies, including asthma, chronic obstructive pulmonary disease (COPD), and lung cancer [20]. This evidence concerns the gene AHR and lung carcinoma.